ONYX PHARMACEUTICALS INC's ticker is and the CUSIP is 683399AB5. A total of 25 filers reported holding ONYX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 51,697,000 | $118,859,000 | 12.48% |
| Raven Rock Credit Master Fund L.P. | 1,000,000 | $2,277,000 | 3.87% |
| WHITEBOX ADVISORS LLC | 23,848,000 | $54,659,000 | 2.87% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,250,000 | $21,061,000 | 2.03% |
| ANGELO GORDON & CO., L.P. | 10,000,000 | $22,769,000 | 1.63% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 37,119,000 | $84,515,000 | 0.84% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,850,000 | $20,226,000,000 | 0.38% |
| Man Investments (CH) AG | 150,000 | $343,000 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,500,000 | $5,712,000 | 0.16% |
| D. E. Shaw & Co., Inc. | 30,580,000 | $69,729,000 | 0.13% |